TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Tillotts Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 270,687 | 307,810 | 235,569 |
Financial expenses | 3,069 | 132 | 1,326 |
Earnings before taxes | 2,894 | 7,736 | 3,885 |
EBITDA | 4,789 | 7,804 | 3,800 |
Total assets | 127,765 | 107,649 | 156,267 |
Current assets | 127,595 | 107,483 | 155,819 |
Current liabilities | 87,854 | 69,989 | 121,808 |
Equity capital | 30,507 | 28,304 | 24,280 |
- share capital | 67 | 67 | 73 |
Employees (average) | 21 | 19 | 18 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 23.9% | 26.3% | 15.5% |
Turnover per employee | 12,890 | 16,201 | 13,087 |
Profit as a percentage of turnover | 1.1% | 2.5% | 1.6% |
Return on assets (ROA) | 4.7% | 7.3% | 3.3% |
Current ratio | 145.2% | 153.6% | 127.9% |
Return on equity (ROE) | 9.5% | 27.3% | 16.0% |
Change turnover | -38,709 | 91,323 | 3,405 |
Change turnover % | -13% | 42% | 1% |
Chg. No. of employees | 2 | 1 | 2 |
Chg. No. of employees % | 11% | 6% | 13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.